Medical & Healthcare TPEs’ Adhesion & Processing Characteristic
By : Nata Kesuma | Friday, March 04 2022 - 16:35 IWST

KRAIBURG TPE Technology
INDUSTRY.co.id - Kuala lumpur, The demand for high-performance engineering plastics such as thermoplastic elastomers (TPEs) has expanded due to recent advances in healthcare and medical equipment. TPE compounds also satisfy the expectations of manufacturers in terms of production and cost efficiency.
TPEs bond easily when processed either through overmolding or co-extrusion with most commonly used structural plastics, eliminating the need for additional adhesives and allowing for faster and more cost-effective processing.
One of the main areas of growth for TPEs is overmolding. Many product designers are utilizing TPEs to add a “soft touch” to a rigid material. KRAIBURG TPE, a global TPE manufacturer of a wide range of TPE products and custom solutions for multiple industries, offers the THERMOLAST® H series HC/AP, developed specifically for healthcare and medical device applications in Asia Pacific. The HC/AP series compounds have a hardness range of 30-90 Shore A and can be used in a variety of applications due to their wide range of hardness from soft to semi-rigid.
Especially for medical and healthcare applications, KRAIBURG TPE’s HC/AP series of TPE compounds can be overmolded to produce comfortable, non-slip, and abrasion-resistant handles, grips, and buttons.
Through multi-component injection molding and extrusion, the THERMOLAST® H HC/AP series has good bonding with polypropylene (PP) and polyethylene (PE) resins, allowing for flexibility in product designs.
As such, the compounds can be overmolded to alter the surface feel, improve aesthetics, and cushion against vibrations.
All-round material solutions
Good haptics, soft-touch properties and elasticity improve function and design, allowing medical device manufacturer to be more creative with their product applications.
KRAIBURG TPE’s HC/AP compounds have a good compression set and are thus fitting for sealing and closure applications.
Furthermore, the compounds can be sterilized in an autoclave at 121°C or with ETO (gas); and have good thermoplastics processing and flowability, stretching the possibility for more medical part designs.
The HC/AP series compounds are safe for use in medical applications and meet standards such as cytotoxicity ISO 10993-5, GB/T 16886.5, bio-compatibility testing according to ISO 10993-5 and GB/T 16886.5, as well as a number of international food contact and medical standards.
Other properties such as good chemical resistance, good sealing and no cytotoxic potential, as well as the ability to be colored into various chromatic effects, present KRAIBURG TPE’s HC/AP compounds as all-round material solutions for the medical and healthcare segments.
Read Also
Today's Industry

Selasa, 17 Mei 2022 - 14:00 WIB
NORD DRIVESYSTEMS at LogiMAT in Stuttgart From 31st May to 2nd June 2022 NORD will present innovative drive solutions for intralogistics
The specialist LogiMAT exhibition in Stuttgart offers as comprehensive overview of the intralogistics and process management market. As one of the market leaders for drive technology, NORD presents…

Selasa, 17 Mei 2022 - 13:00 WIB
President Jokowi Invites US CEOs to Boost Cooperation with Indonesia
President Joko “Jokowi” Widodo has invited company CEOs in the United States to boost cooperation with ASEAN countries, particularly Indonesia.

Selasa, 17 Mei 2022 - 12:28 WIB
President Jokowi, ASEAN Leaders Attend Dinner Hosted by US President
President Joko “Jokowi” Widodo Thursday (05/12) attended a dinner with the leaders of ASEAN countries hosted by President of the United States Joe Biden at the White House, Washington D.C.

Selasa, 17 Mei 2022 - 11:23 WIB
TPE unleashes benefits for pet accessories
The pet care market is rapidly expanding as pet ownership increases, as does spending on pet food, grooming tools, and accessories. Pet owners are significantly concerned about the prevalence…

Jumat, 13 Mei 2022 - 16:15 WIB
Robocash Group reached 2 BN USD of disbursement and issued audited financial report of 2021
Robocash Group publishes the audited combined financial statements for the year ended 31 December 2021. The Group reached an all-time high 2 BN USD of issued financing and is expected to increase…
News Comment